# An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

> **NCT00861042** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 69 (actual)

## Conditions studied

- Painful Diabetic Neuropathy

## Interventions

- **DRUG:** SPM927/Lacosamide

## Key facts

- **NCT ID:** NCT00861042
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2004-12
- **Final completion:** 2005-03
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2024-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00861042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00861042, "An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00861042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*